Yagi Akiho, Uchida Ryuji, Hamamoto Hiroshi, Sekimizu Kazuhisa, Kimura Ken-Ichi, Tomoda Hiroshi
Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Institute of Medical Mycology, Teikyo University, Tokyo, Japan.
J Antibiot (Tokyo). 2017 May;70(5):685-690. doi: 10.1038/ja.2017.23.
An in vivo-mimic silkworm infection model with Mycobacterium smegmatis was established. When silkworms were raised at 37 °C following an injection of M. smegmatis cells (1.25 × 10 CFU larva g) into the silkworm hemolymph, they died within 48 h. Under these conditions, four microbial peptides with anti-M. smegmatis activity, lariatin A, calpinactam, lysocin E and propeptin, exerted therapeutic effects in a dose-dependent manner, and these are also clinically used agents that are active against Mycobacterium tuberculosis. These results indicate that the silkworm infection model with M. smegmatis is practically useful for the screening of therapeutically effective anti-M. tuberculosis antibiotics.
建立了耻垢分枝杆菌的体内模拟家蚕感染模型。当向家蚕血淋巴注射耻垢分枝杆菌细胞(1.25×10 CFU/幼虫·克)后,在37°C饲养家蚕时,它们会在48小时内死亡。在这些条件下,四种具有抗耻垢分枝杆菌活性的微生物肽,lariatin A、calpinactam、溶菌素E和前肽素,以剂量依赖的方式发挥治疗作用,并且这些也是临床上用于对抗结核分枝杆菌有活性的药物。这些结果表明,耻垢分枝杆菌家蚕感染模型对于筛选治疗有效的抗结核分枝杆菌抗生素实际上是有用的。